The page is the record's research on the issuer — no analyst, no rating, no view. # CRESCENT BIOPHARMA, INC. (NASDAQ: CBIO) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing CRESCENT BIOPHARMA, INC. is listed on NASDAQ under the ticker CBIO. Its ISIN is US38000Q2012 and its LEI is 549300TZ84FFU2J2J459. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is the Cayman Islands. Its listing status is listed, not halted. ## The disclosure read The record holds 81 filings across 34 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 8 days. The latest filing is a regulatory filing dated 2026-10-27, 12 days before the record date. The filings comprise 31 directors' dealings, 24 regulatory filings, 11 prospectuses, 8 results, 4 AGM/EGM filings and 3 corporate news items. On NASDAQ the median cadence gap is 6.0 days, the median filing count is 52 and the median latency is 5.0 days. In the sector 2834 Pharmaceutical Preparations, the median cadence gap is 6.0 days, the median filing count is 63.0 and the median latency is 4.0 days. ## Auditor The auditor of record is PricewaterhouseCoopers LLP, located in Boston, Massachusetts. The record holds no auditor changes. ## Events and halts The record holds one listing dated 2025-11-06. It holds no delisting, no name change and no segment move. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag shows listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin) - https://data.sec.gov/submissions/CIK0001253689.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NASDAQ/CBIO (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1253689/000162828026011983/cbio-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/CBIO (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/CBIO · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp